PMDA drug package insert
レザルタス配合錠LD
PMDA Prescription drug · 第一三共株式会社 · package insert Aug 25, 2026
Key facts
| Brand names | レザルタス配合錠LD, レザルタス配合錠HD |
|---|---|
| Nonproprietary names | オルメサルタン メドキソミル・アゼルニジピン配合剤 |
| Companies | 製造販売元／第一三共株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 高親和性ARB/持続性Ca拮抗薬配合剤 |
| Therapeutic category codes | 872149 |
| YJ codes | 2149115F1026, 2149115F2022 |
| Approval numbers | 22200AMX00244, 22200AMX00245 |
| Package insert edition | 第8版 |
| Package insert date | Aug 25, 2026 |
| PMDA document key | 430574_2149115F1026_1 |
| PMDA company code | 430574 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: